Zobrazeno 1 - 10
of 10
pro vyhledávání: '"міфепристон"'
Publikováno v:
Репродуктивне здоров'я жінки; № 9-10 (2021); 94-99
Reproductive health of woman; № 9-10 (2021); 94-99
Reproductive health of woman; No. 9-10 (2021); 94-99
Reproductive health of woman; № 9-10 (2021); 94-99
Reproductive health of woman; No. 9-10 (2021); 94-99
The objective: to conduct a comparative analysis of the efficacy and tolerability of antigestagens (mifepristone) and gonadotropin-releasing hormone agonists (aGnRH) as part of adjuvant therapy for the prevention of the recurrence of uterine fibroids
Publikováno v:
Bukovinian Medical Herald; Vol. 25 No. 3 (99) (2021); 132-137
Буковинский медицинский вестник; Том 25 № 3 (99) (2021); 132-137
Буковинський медичний вісник; Том 25 № 3 (99) (2021); 132-137
Буковинский медицинский вестник; Том 25 № 3 (99) (2021); 132-137
Буковинський медичний вісник; Том 25 № 3 (99) (2021); 132-137
The purpose of the work. To study the effectiveness of the combined treatment of uterine leiomyoma (UL), taking into account the possibility of realizing reproductive function.Material and methods. The total number of women of reproductive age examin
Publikováno v:
Reproductive Endocrinology; № 54 (2020); 27-31
Репродуктивная эндокринология; № 54 (2020); 27-31
Репродуктивна ендокринологія; № 54 (2020); 27-31
Репродуктивная эндокринология; № 54 (2020); 27-31
Репродуктивна ендокринологія; № 54 (2020); 27-31
Objective of the study was to determine the characteristics of hormonal homeostasis in women with uterine leiomyoma in the course of treatment.Materials and methods. The hormonal status of 60 women with uterine leiomyoma at the age of 26–45 years w
Publikováno v:
Репродуктивне здоров'я жінки; № 3 (2021); 81-86
Reproductive health of woman; № 3 (2021); 81-86
Reproductive health of woman; No. 3 (2021); 81-86
Reproductive health of woman; № 3 (2021); 81-86
Reproductive health of woman; No. 3 (2021); 81-86
The objective: to determine the association of estrogen receptor gene polymorphisms ESR1 and progesterone PGR with the development of uterine leiomyoma (UL) and to develop a patient management algorithm based on the results of ultrasound and genetic
Publikováno v:
Репродуктивна ендокринологія; № 39 (2018); 55-58
Репродуктивная эндокринология; № 39 (2018); 55-58
Reproductive Endocrinology; № 39 (2018); 55-58
Репродуктивная эндокринология; № 39 (2018); 55-58
Reproductive Endocrinology; № 39 (2018); 55-58
The article deals modern approaches used of mifepristone in order to prepare the cervix for delivery. The results of a study of 222 patients in the gestation period of 37–42 gestation weeks which given orally administered 200 mg of mifepristone at
Autor:
Романенко, Т. Г., Морозова, О. В.
Publikováno v:
Reproductive Health of Woman; 2022, Vol. 56 Issue 1, p8-12, 5p
Autor:
Толстанова, Г. О.
Publikováno v:
Reproductive Health of Woman; 2021, Vol. 54/55 Issue 9/10, p94-99, 6p
Publikováno v:
Репродуктивне здоров'я жінки; № 1 (2022); 8-12
Reproductive health of woman; № 1 (2022); 8-12
Reproductive health of woman; No. 1 (2022); 8-12
Reproductive health of woman; № 1 (2022); 8-12
Reproductive health of woman; No. 1 (2022); 8-12
The article is devoted to modern directions for improving of the medical care for women with artificial interruption of pregnancy, in particular, the use of non-surgical methods of abortion. One of the most important tasks of an obstetrician-gynecolo
Autor:
Tertyshnik, D. Yu.
Tertyshnik D. Yu. PREGNANCY AND CHILDBIRTH IN WOMEN WITH PLACENTAL DYSFUNCTION CONDITIONED BY PRE-GESTIVE DIABETES MELLITUS = ВАГІТНІСТЬ ТА ПОЛОГИ У ЖІНОК З ПЛАЦЕНТАРНОЮ ДИСФУНКЦІЄЮ, ОБУМОВЛЕН
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640e84584bcb15753f382877deb98ac2
Publikováno v:
Вісник соціальної гігієни та організації охорони здоров'я України.
Мета: провести аналіз сучасної вітчизняної та зарубіжної літератури стосовно причин виникнення, етіопатогенезу лейоміоми матки, сучас